General Manager Enrique Sánchez and CSO Andrés Da Silva will lead the delegation to explore new strategic alliances at Europe’s main biotechnology partnering event.

Bflow SL will attend Bio-Europe 2025, the most important partnering event for the biopharmaceutical industry in Europe, which will be held from November 3 to 5 in Vienna, Austria.

The company will be represented at the highest level by its General Manager, Enrique Sánchez, and its CSO, Andrés Da Silva.

Bio-Europe brings together thousands of executives and scientists from around the world, offering an unparalleled platform for networking and business development. The participation of Bflow SL underlines its commitment to innovation and the active search for synergies within the BioPharma ecosystem.

The main objective will be to present our latest advances in Organ-On-A-Chip technology, identify strategic partners and explore collaboration opportunities that accelerate the development of new platforms, and demonstrate how Bflow’s technology can optimize biopharmaceutical R&D.